Application Information

This drug has been submitted to the FDA under the reference 205489/001.

Names and composition

"COTEMPLA XR-ODT" is the commercial name of a drug composed of METHYLPHENIDATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
205489/001 COTEMPLA XR-ODT METHYLPHENIDATE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL 8.6MG
205489/002 COTEMPLA XR-ODT METHYLPHENIDATE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL 17.3MG
205489/003 COTEMPLA XR-ODT METHYLPHENIDATE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL 25.9MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021514/001 DAYTRANA METHYLPHENIDATE FILM, EXTENDED RELEASE/TRANSDERMAL 10MG per 9HR (1.1MG per HR)
021514/002 DAYTRANA METHYLPHENIDATE FILM, EXTENDED RELEASE/TRANSDERMAL 15MG per 9HR (1.6MG per HR)
021514/003 DAYTRANA METHYLPHENIDATE FILM, EXTENDED RELEASE/TRANSDERMAL 20MG per 9HR (2.2MG per HR)
021514/004 DAYTRANA METHYLPHENIDATE FILM, EXTENDED RELEASE/TRANSDERMAL 30MG per 9HR (3.3MG per HR)
205489/001 COTEMPLA XR-ODT METHYLPHENIDATE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL 8.6MG
205489/002 COTEMPLA XR-ODT METHYLPHENIDATE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL 17.3MG
205489/003 COTEMPLA XR-ODT METHYLPHENIDATE TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE/ORAL 25.9MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved